State Medicaid DUR Board Meeting - Revision 4
This is a Notice Revision
You are currently viewing a revision of a notice. This is a previous copy of a notice that has been published more recently. To view the current version of this notice, click here.
Please Note: Only the files that were associated to this version are included in the Download Attachments section. If that section does not display, all attachments were removed from this version of the notice.
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Drug Utilization Review Board
Notice Information
- Notice Title
- State Medicaid DUR Board Meeting
- Notice Tags
- Medicaid, Health Care
- Notice Type(s)
- Meeting, Hearing
- Event Start Date & Time
- May 8, 2025 07:15 AM
- Event End Date & Time
- May 8, 2025 08:30 AM
- Event Deadline Date & Time
- 05/08/25 08:30 AM
- Description/Agenda
- Drug Utilization Review Board Meeting Agenda Thursday, May 8, 2025 7:15 a.m. to 8:30 a.m. Google Meet joining info Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Sharon Weinstein, MD a) Welcome and Introductions b) Review and Approval of Minutes 2) P&T Committee Update - Ngan Huynh, PharmD 3) Review a) Alhemo (concizumab-mtci) DRRC Presentation - Monet Luloh, PharmD i) Committee Discussion/Questions b) Qfitlia (fitusiran) Presentation - Luis Moreno, PharmD i) Committee Discussion/Questions c) Public Comment i) Biogen: Skyclarys - Lynda Finch, PhD d) Alhemo (concizumab-mtci) Prior Authorization - Ngan Huynh, PharmD i) Committee Discussion/Questions ii) Committee Action e) Qfitlia (fitusiran) Prior Authorization - Luis Moreno, PharmD i) Committee Discussion/Questions ii) Committee Action f) Skyclarys (omaveloxolone) Prior Authorization - Luis Moreno, PharmD i) Committee Discussion/Questions ii) Committee Action 4) Next Meeting a) June 12, 2025 - Review of Tryvio (aprocitentan) as adjunct for hypertension, Zynteglo (betibeglogene autotemcel), and GLP-1 Medications for Weight Loss prior authorization forms. 5) Adjourned - Sharon Weinstein, MD
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
- Notice of Electronic or Telephone Participation
- Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Luis Moreno
- Contact Email
- lmoreno@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- April 24, 2025 04:34 PM
- Notice Last Edited On
- May 07, 2025 09:56 AM
- Deadline Date
- May 8, 2025 08:30 AM